menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Emerging Markets' ×
Andy Tisman
How wellness trends and emerging markets growth are boosting sales in over-the-counter products.
Read More
Lisa Marie Saldanha
This is the first in a series of blogs about new models to improve collaborative academic research efficiency and increase its probability of success.
Read More
Joan Drucker
How the industry is collaborating to rapidly develop better diagnostics and innovative vaccines in response to this global healthcare crisis.
Read More
Passion drives my work
A clinical research associate shares what clinical research means to him and the patients he works with.
Read More
Daniel Vazquez
Latin America is a center for biopharmaceutical growth, but shifting regulations mean companies need keen insights and boots on the ground to navigate this complex marketplace.
Read More
Simon Francis
How to choose the right meeting environment for investigator training.
Read More
Ross Horsburgh
Rob-Stolper
EricaCaveney
Diabetes is a major global health issue that affects millions of people worldwide. And trends suggest that is only going to get worse. Consider these facts: In 2011, 366 million people had diabetes. That number is projected to rise to 592 million by 2035, according to the International Diabetes Foundation (IDF).  Diabetes caused 4.6 million deaths in 2011, according to the World Health Organization ( WHO ). It accounted for at least $465 billion in healthcare expenditures. This was approximately 11 percent of the total healthcare expenditures in adults age 20 to 79.   In the United States, diabetes affects 25.8 million people of all ages -- approximately 8.3% of the U.S. population, according to the American Diabetes...
Read More
Naz Haji
Clearer regulations, better infrastructure, strong talent and rich pools of patients make India an attractive destination for clinical trials once again.
Read More